Sponsor:
Yale University
Code:
NCT05291676
Conditions
Influenza
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Accepted
Interventions
Fluzone
Fluad
Brief summary:
Conditions
Influenza
Study ID
NCT05291676
Start date
Nov 6, 2023
Status verified date
Nov, 2026
Completion date
May, 2029
Anticipated
Primary completion date
May, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Accepted
Enrollment
96 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Prevention
Arms
active comparator: 21-30 standard dose Fluad
active comparator: 21-30 high dose Fluzone
experimental: ≥65 years standard dose Fluad
experimental: ≥65 years high dose Fluzone
Interventions
Fluzone
Fluad
Primary outcome measure
Central contacts
Locations
Yale School of Medicine
Recruiting
New Haven, Connecticut, United States, 06520
Contacts
Sponsor
Yale University
Last update posted
Nov 10, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-17. This information was provided to ClinicalTrials.gov by Yale University on 2026-11-10. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.